According to a new report published by Introspective Market Research, titled, Oxygenators Market by Product (Membrane Oxygenators and Bubble Oxygenators), By Material (Polypropylene, Polymethylpentene, Silicone, and Others), By Flow Rate (Low Flow and High Flow), By Patient Age Group (Adult, Pediatric, and Neonatal), By End-use Industry (Hospitals, Ambulatory Surgical Centers, and Others), The Global Oxygenators Market Size Was Valued at USD 240.34 Million in 2023 and is Projected to Reach USD 416.51 Million by 2032, Growing at a CAGR of 6.3%. The Oxygenators Market encompasses medical devices designed to replace the function of the lungs by adding oxygen to the blood and removing carbon dioxide. These critical devices are primarily used during cardiopulmonary bypass (CPB) procedures in cardiac surgery, where the heart and lungs are temporarily stopped, as well as in extracorporeal membrane oxygenation (ECMO) for patients with severe respiratory or cardiac failure. Oxygenators are vital life-support systems, enabling surgeons to operate on a still heart and providing crucial time for critically ill patients to recover.
Modern oxygenators, particularly membrane oxygenators, offer significant advantages over older bubble oxygenators, including reduced blood trauma, lower risk of embolism, and more precise gas exchange control. Their ability to maintain physiological conditions for extended periods has made complex cardiac surgeries safer and more effective, while also expanding the therapeutic options for acute respiratory distress syndrome (ARDS) and other severe pulmonary conditions. Key industries driving this market are medical device manufacturing, cardiac surgery, and critical care medicine, all committed to advancing life-saving technologies and improving patient outcomes.
A significant growth driver for the Oxygenators Market is the rising global incidence of cardiovascular diseases (CVDs) and the increasing number of complex cardiac surgeries performed worldwide. Conditions such as coronary artery disease, valvular heart disease, and congenital heart defects often necessitate open-heart surgery, during which cardiopulmonary bypass (CPB) and, consequently, oxygenators are indispensable. As lifestyle factors contribute to a growing burden of CVDs and advancements in surgical techniques enable more complex interventions, the demand for reliable and efficient oxygenators for these life-saving procedures continues to escalate.
A key market opportunity for the Oxygenators Market lies in the expanding application of Extracorporeal Membrane Oxygenation (ECMO) for severe respiratory and cardiac failure. Beyond traditional cardiac surgery, ECMO is increasingly recognized as a vital support system for patients with acute respiratory distress syndrome (ARDS), severe pneumonia (including cases related to global health crises), and cardiogenic shock, who do not respond to conventional treatments. The growing understanding of ECMO's benefits and the expansion of specialized ECMO centers globally present a substantial opportunity for oxygenator manufacturers to develop advanced, long-term support systems and expand their presence in critical care medicine.
Oxygenators Market, Segmentation
Product
-
The Product segment is further classified into Membrane Oxygenators and Bubble Oxygenators. Among these, the Membrane Oxygenators sub-segment accounted for the highest market share in 2023. Membrane oxygenators have become the gold standard in cardiopulmonary bypass and ECMO due to their superior performance and safety profiles compared to older bubble oxygenators. They facilitate gas exchange across a semi-permeable membrane, mimicking natural lung function more closely, which significantly reduces blood trauma, inflammation, and the risk of gas embolism. This results in better patient outcomes, making them the preferred choice for a wide range of cardiac surgeries and critical care applications, solidifying their dominant market position.
Material
- The Material segment is further classified into Polypropylene, Polymethylpentene, Silicone, and Others. Among these, the Polymethylpentene sub-segment accounted for the highest market share in 2023. Polymethylpentene (PMP) is a rapidly growing and preferred material for the gas exchange membranes in oxygenators, largely due to its excellent gas transfer properties and high biocompatibility. PMP membranes offer superior performance in terms of oxygenation efficiency and carbon dioxide removal, while also exhibiting lower plasma leakage, which is crucial for reducing the risk of complications during extended use. Its improved performance characteristics make it highly favored for advanced membrane oxygenator designs, particularly for long-term ECMO applications, contributing to its leading market share.
Some of The Leading/Active Market Players Are-
- Medtronic plc (Ireland)
- LivaNova PLC (UK)
- Terumo Corporation (Japan)
- Getinge AB (Sweden)
- Nipro Corporation (Japan)
- Sorin Group (now LivaNova, UK)
- Eurosets S.p.A. (Italy)
- XENIOS AG (Fresenius Medical Care AG & Co. KGaA, Germany)
- Braile Biomedica (Brazil)
- OriGen Biomedical, Inc. (USA)
- Spectrum Medical Ltd (UK)
- MicroPort Scientific Corporation (China)
- Jiangsu Best Medical Product Co., Ltd. (China)
- Perfusion System, Inc. (USA)
- Landanger (France)
- other active players.
Key Industry Developments
-
In April 2023, Medtronic announced the launch of its new generation of perfusion system, including an advanced oxygenator, designed to enhance patient safety and clinical outcomes during cardiac surgery. This launch highlights continuous innovation aimed at improving the efficiency and biocompatibility of oxygenation devices. The new system integrates features for easier setup and monitoring, addressing the evolving needs of cardiac surgical teams.
- In November 2022, LivaNova received expanded regulatory clearance for its latest membrane oxygenator, allowing for extended use in pediatric and neonatal ECMO applications. This development underscores the growing demand for specialized oxygenators tailored to younger patient populations. The clearance allows clinicians greater flexibility in managing critically ill infants and children, expanding the therapeutic reach of life-support technologies.
Key Findings of the Study
- Membrane Oxygenators dominate the market due to superior safety and performance.
- Polymethylpentene is the leading material due to its advanced gas exchange properties.
- Rising incidence of cardiovascular diseases drives demand for oxygenators.
- Expanding applications of ECMO in critical care present a significant opportunity.
- The market is focused on enhancing biocompatibility and extending usage duration.
